Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system.
The renal kallikrein-kinin system has been shown to be important in the development of hypertension, but its precise role remains to be determined. The recent use of mutant rats that are deficient in plasma kininogens and hence incapable of generating kinin in the renal tubules has facilitated elucidation of the involvement of kinin in hypertension. In this article, Masataka Majima and Makoto Katori provide evidence that the renal kallikrein-kinin system plays a crucial role in the development of hypertension and discuss a novel rationale for developing effective new antihypertensive drugs.
Majima
M
M
Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Katori
M
M
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D016234:Kallikrein-Kinin System / Q000502:physiology*; D007668:Kidney / Q000503:physiopathology*
D000959:Antihypertensive Agents